MIRA INFORM REPORT

 

 

Report Date :

06.08.2014

 

IDENTIFICATION DETAILS

 

Name :

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

 

 

Registered Office :

No.160, KCI Chambers, 2nd Floor, 5th Main Road, Chamarajpet, Bangalore-560018, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

22.06.2004

 

 

Com. Reg. No.:

08-034182

 

 

Capital Investment / Paid-up Capital :

Rs. 27.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24231KA2004PTC034182

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Importer and Exporter of pharmaceutical, drugs, surgical items.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 90000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track.

 

The company has recorded some accumulated losses, there also seems dip in the turnover during 2013.

 

However, trade relations are reported as fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

NEWS

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Murli

Designation :

Finance Manager

Contact No.:

91-9980909206

Date :

05.08.2014

 

 

LOCATIONS

 

Registered Office / Corporate Office :

No.160, KCI Chambers, 2nd Floor, 5th Main Road, Chamarajpet, Bangalore-560018, Karnataka, India

Tel. No.:

91-80-42154535 / 36

Mobile No.:

91-9980909206 (Mr. Murli)

Fax No.:

91-80-42154537 / 42154538

E-Mail :

murali@trigenesislife.co.in

vinod@trigenesislife.co.in  

info@trigenesislife.co.in

Website :

http://www.trigenesislife.co.in

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Vinod Nahar

Designation :

Managing Director

Address :

121 Bull Temple Road, Cross, Opposite Maratha Hostel, Bangalore – 560019, Karnataka, India

Date of Birth/Age :

12.08.1974

Date of Appointment :

07.08.2008

DIN No. :

01562249

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110KA1989PTC009974

R S M PHARMA PRIVATE LIMITED

Director

25/09/2007

17/01/2001

-

Active

NO

2

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Managing director

07/08/2008

22/06/2004

-

Active

NO

3

U24239KA2007PTC043662

EUGENE BIOSCIENCES PRIVATE LIMITED

Director

22/08/2007

22/08/2007

-

Active

NO

4

U51909KA2010PTC054101

Frisia Healthcare Services Private Limited

Director

17/06/2010

17/06/2010

-

Active

NO

5

U51909KA2010PTC055077

Plasmagen Biosciences Private Limited

Director

07/09/2010

07/09/2010

-

Active

NO

6

U51397KA2010PTC055190

Splendina Healthcare Private Limited

Director

17/09/2010

17/09/2010

-

Active

NO

7

U51900KA2011PTC056703

RSM Lifecare India Private Limited

Director

19/01/2011

19/01/2011

-

Active

NO

8

U52300KA2012PTC065974

Hospitalis Supply Solutions Private Limited

Director

24/09/2012

24/09/2012

14/01/2014

Active

NO

 

 

Name :

Mr. Rahul Jain

Designation :

Director

Address :

# 21 Market Road, Basavangudi, Bangalore - 560 004, Karnataka, India

Date of Birth/Age :

12.06.1985

Date of Appointment :

18.06.2007

DIN No. :

01589726

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Director

18/06/2007

18/06/2007

-

Active

NO

2

U24100TN2014PTC094601

VEROGEN HEALTHCARE PRIVATE LIMITED

Director

16/01/2014

16/01/2014

-

Active

NO

 

 

Name :

Mr. Gopal Sarda

Designation :

Director

Address :

#792/A 5th Cross, Mahalaxmi Layout, Bangalore -560086, Karnataka, India

Date of Birth/Age :

03.05.1949

Date of Appointment :

18.06.2007

DIN No. :

01589702

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Director

18/06/2007

18/06/2007

-

Active

NO

2

U24239KA2007PTC043662

EUGENE BIOSCIENCES PRIVATE LIMITED

Director

22/08/2007

22/08/2007

-

Active

NO

3

U25200KA2011PTC058029

Wiz Plast Private Limited

Director

07/04/2011

07/04/2011

-

Active

NO

4

U25209KA1996PTC019658

UNNATI PLASTICS PRIVATE LIMITED

Director

29/09/2012

01/02/2012

-

Active

NO

 

 

Name :

Mr. Kapil Kumar Bhawarlal Jain

Designation :

Director

Address :

# 92 H.B. Samaja Road, Basavanagudi, Bangalore -560004, Karnataka, India

Date of Birth/Age :

29.09.1983

Date of Appointment :

18.06.2007

DIN No. :

01597267

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231KA2004PTC034182

TRIGENESIS LIFESCIENCES PRIVATE LIMITED

Director

18/06/2007

18/06/2007

-

Active

NO

2

U51909KA2010PTC055077

Plasmagen Biosciences Private Limited

Director

07/09/2010

07/09/2010

-

Active

NO

3

U24100TN2014PTC094601

VEROGEN HEALTHCARE PRIVATE LIMITED

Director

16/01/2014

16/01/2014

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Murli

Designation :

Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

No. of Shares

 

Vinod Nahar

530000

Chandanbala

266000

Kapil Kumar Jain

40000

Pushpa Devi

270000

Rahul Jain

50000

Santosh Devi

270000

S.G. Sarda

10000

Unnathi Polymers Private Limited, India

440000

Anitha Nahar

35000

Asha nahar

85000

C. L. Nahar

290000

Pinky H. V.

160000

Vijay Nahar

250000

Ganpath Lal

1000

Ganpath Lal (HUF)

1000

Bhawar Lal

1000

Dinesh Kumar

1000

 

 

Total

2700000

 

AS ON 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

16.30

Directors or relatives of Directors

63.70

Other top fifty shareholders

20.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Importer and Exporter of pharmaceutical, drugs, surgical items.

 

 

GENERAL INFORMATION

 

Supplier :

·         Kamada Limited

·         Gufic Bioscience Limited

·         Global Health Care Solution

 

·          

Customer :

·         Icon Hospital

·         Healthcare Hospital

·         Mayuka Labs Private Limited

·         Apotecas Private Limited – Sri Lanka

 

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

·         Bank of India

·         The Hongkong and Shanghai Banking Corporation Limited

·         HDFC Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Loans from Bank

 

 

Bank of India – car loans

[Secured hypothecation of stock and personal guarantee of director]

0.018

0.156

SHORT TERM BORROWINGS

 

 

From Bank

 

 

Bank O/D A/C - HDFC Bank – CC A/C

17.361

0.000

Loans from others – Buyers Credit

24.060

0.000

Total

41.439

0.156

 

 

 

Banking Relations :

--

 

 

Financial Institutions :

·         Religare Finvest Limited

·         Magma FinCorp Limited

 

 

Auditors :

 

Name :

Rishi R. Jain

Chartered Accountants

Address :

No. 5, Vishwanath Roa Road, Madhavanagar, Bangalore – 560001, Karnataka, India

PAN No.:

ABZPB5750E

Tel. No.:

91-80-41266917

Mobile No.:

91-9341224067

 

 

Holding Company :

Unnathi Polymers Private Limited, India

 

 

Subsidiaries :

Eugene Biosciences Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2700000

Equity Shares

Rs.10/- each

Rs.27.000 Millions

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

27.000

27.000

27.000

(b) Reserves & Surplus

(12.810)

(16.208)

(17.638)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

7.000

7.000

0.000

Total Shareholders’ Funds (1) + (2)

21.190

17.792

9.362

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

6.028

35.974

44.246

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

6.028

35.974

44.246

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

41.421

0.000

0.000

(b) Trade payables

0.234

6.782

0.118

(c) Other current liabilities

0.000

0.000

0.000

(d) Short-term provisions

6.007

6.863

3.911

Total Current Liabilities (4)

47.662

13.645

4.029

 

 

 

 

TOTAL

74.880

67.411

57.637

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3.151

4.111

5.736

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1.000

1.000

0.099

(c) Deferred tax assets (net)

0.514

0.324

0.144

(d)  Long-term Loan and Advances

3.451

1.088

3.337

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

8.116

6.523

9.316

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1.764

3.012

11.075

(c) Trade receivables

7.505

17.626

1.591

(d) Cash and cash equivalents

1.862

11.304

12.822

(e) Short-term loans and advances

25.441

19.800

14.716

(f) Other current assets

30.192

9.146

8.117

Total Current Assets

66.764

60.888

48.321

 

 

 

 

TOTAL

74.880

67.411

57.637

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Revenue from operations

172.564

215.189

182.039

 

Other Income

 

 

 

 

TOTAL

172.564

215.189

182.039

 

 

 

 

 

Less

EXPENSES

 

 

 

 

TOTAL

169.355

213.940

182.016

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

3.209

1.249

0.023

 

 

 

 

 

Less

TAX

(0.189)

(0.180)

(0.155)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

3.398

1.429

0.178

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

20.121

27.125

28.503

 

TOTAL EARNINGS

20.121

27.125

28.503

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

1.259

0.529

0.066

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

 

31.03.2012

 

31.03.2011

 

PAT / Total Income

(%)

1.97

0.66

0.10

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.86

0.58

0.01

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.37

1.89

0.04

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.07

0.00

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

2.23

2.02

4.72

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.40

4.46

11.99

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

27.000

27.000

27.000

Reserves & Surplus

(17.638)

(16.208)

(12.810)

Share Application money pending allotment

0.000

7.000

7.000

Net worth

9.362

17.792

21.190

 

 

 

 

long-term borrowings

44.246

35.974

6.028

Short term borrowings

0.000

0.000

41.421

Total borrowings

44.246

35.974

47.449

Debt/Equity ratio

4.726

2.022

2.239

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

182.039

215.189

172.564

 

 

18.210

(19.808)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

182.039

215.189

172.564

Profit/(Loss) After Tax

0.178

1.429

3.398

 

0.10%

0.66%

1.97%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-------

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

------

22]

Litigations that the firm / promoter involved in

------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

------

26]

Buyer visit details

------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10391041

30/11/2012

19,500,000.00

HDFC BANK LIMITED

HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL W 
, MUMBAI, MAHARASHTRA - 400013, INDIA

B63772529

 

UNSECURED LOANS

 

PARTICULAR

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Loans from bank

[Secured hypothecation of stock and personal guarantee of director]

4.210

3.443

Loans from shareholders and directors

1.800

32.375

 

 

 

Total

6.010

35.818

 

 

FIXED ASSETS

 

·         Computer

·         Furniture and Fitting

·         Office Equipment

·         Xerox Machine

·         Fax Machine

·         Refrigerator

·         LCD Projector

·         Mobile Phone

·         Motor Car

·         Air Conditioner

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.87

UK Pound

1

Rs.102.67

Euro

1

Rs.81.70

 

 

INFORMATION DETAILS

 

Information Gathered by :

HNA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

SNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

2

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

NB

New Business

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.